Finally, we experimentally validated the predicted targets using the MH7A cell model and found that the anti-RA mechanisms of ARSHs were closely related to the down-regulation of Bcl-2, up-regulation of Bax, and inhibition of SRC/STAT3/MAPK3 expression. This evidence concerns the gene BCL2 and rheumatoid arthritis.